Parkinson Disease/ Parkinsonian Disorders

Citations 81-90 of 350 total displayed.

Past content (since Jan 1998):

Original Contributions
Screen for Excess FMR1 Premutation Alleles Among Males With Parkinsonism

Jeremy Kraff; Hiu-Tung Tang; Roberto Cilia; Margherita Canesi; Gianni Pezzoli; Stefano Goldwurm; Paul J. Hagerman; Flora Tassone
Arch Neurol 2007; 64: 1002-1006. [Abstract] [Full text] [PDF]  

Research Letters
Glucocerebrosidase Mutations and Risk of Parkinson Disease in Chinese Patients

Eng-King Tan; Justina Tong; Stephanie Fook-Chong; Yuen Yih; Meng-Cheong Wong; Ratnagopal Pavanni; Yi Zhao
Arch Neurol 2007; 64: 1056-1058. [Extract] [Full text] [PDF]  

Original Contributions
Risk Factors for the Development of Pedal Edema in Patients Using Pramipexole

Galit Kleiner-Fisman; David N. Fisman
Arch Neurol 2007; 64: 820-824. [Abstract] [Full text] [PDF]  

Original Contributions
Inflammatory Cytokine Gene Polymorphisms and Increased Risk of Parkinson Disease

Angelika D. Wahner; Janet S. Sinsheimer; Jeff. M. Bronstein; Beate Ritz
Arch Neurol 2007; 64: 836-840. [Abstract] [Full text] [PDF]  

Observations
Manganese-Induced Parkinsonism Associated With Methcathinone (Ephedrone) Abuse

Rob M. A. de Bie; Richard M. Gladstone; Antonio P. Strafella; Ji-Hyun Ko; Anthony E. Lang
Arch Neurol 2007; 64: 886-889. [Abstract] [Full text] [PDF]  

Clinical Trials
Randomized, Double-blind, Placebo-Controlled Trial on Symptomatic Effects of Coenzyme Q₁₀ in Parkinson Disease

Alexander Storch; Wolfgang H. Jost; Peter Vieregge; Jörg Spiegel; Wolfgang Greulich; Joachim Durner; Thomas Müller; Andreas Kupsch; Henning Henningsen; Wolfgang H. Oertel; Gerd Fuchs; Wilfried Kuhn; Petra Niklowitz; Rainer Koch; Birgit Herting; Heinz Reichmann; for the German Coenzyme Q₁₀ Study Group
Arch Neurol 64.7.nct60005. [Abstract] [Full text] []  

Original Contributions
Transdermal Rotigotine: Double-blind, Placebo-Controlled Trial in Parkinson Disease

Joseph Jankovic; Ray L. Watts; Wayne Martin; Babak Boroojerdi; for the SP 512 Rotigotine Transdermal System Clinical Study Group
Arch Neurol 2007; 64: 676-682. [Abstract] [Full text] [PDF] [ Notice of Redundant Publication ]  

Original Contributions
Risk Factors for the Development of Pedal Edema in Patients Using Pramipexole

Galit Kleiner-Fisman; David N. Fisman
Arch Neurol 64.6.noc60158. [Abstract] [Full text] []  

Original Contributions
Mutation of the Linker Region of the Polymerase -1 (POLG1) Gene Associated With Progressive External Ophthalmoplegia and Parkinsonism

Gavin Hudson; Andrew M. Schaefer; Robert W. Taylor; Watcharee Tiangyou; Andrew Gibson; Graham Venables; Philip Griffiths; David J. Burn; Douglass M. Turnbull; Patrick F. Chinnery
Arch Neurol 2007; 64: 553-557. [Abstract] [Full text] [PDF]  

Original Contributions
Smoking, Caffeine, and Nonsteroidal Anti-inflammatory Drugs in Families With Parkinson Disease

Dana B. Hancock; Eden R. Martin; Jeffrey M. Stajich; Rita Jewett; Mark A. Stacy; Burton L. Scott; Jeffery M. Vance; William K. Scott
Arch Neurol 2007; 64: 576-580. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35